Yearly zoledronic acid in postmenopausal osteoporosis.

Yearly zoledronic acid in postmenopausal osteoporosis.

Библиографические подробности
Главные авторы:	Poole, K, Kaptoge, S, Reeve, J
Формат:	Journal article
Язык:	English
Опубликовано:	2007

Схожие документы

EFFECT OF ZOLEDRONIC AND IBANDRONIC ACIDS ON BONE METABOLISM IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
по: O V Yakushevskaya, и др.
Опубликовано: (2012-08-01)

Treatment of postmenopausal osteoporosis, patient perspectives &ndash; focus on once yearly zoledronic acid
по: Raj Carmona, и др.
Опубликовано: (2009-07-01)

IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
по: Lin H, и др.
Опубликовано: (2021-07-01)

Risk factors analysis in postmenopausal osteoporosis fragility fracture patients after treated with zoledronic acid
по: Ding Yue, и др.
Опубликовано: (2017-09-01)

Intravenous zoledronate for postmenopausal women with osteopenia and osteoporosis: a systematic review and metanalysis
по: Fernanda Martins Gazoni, и др.
Опубликовано: (2023-05-01)

Zoledronic acid does not slow spinal radiographic progression of osteoarthritis in postmenopausal women with osteoporosis and radiographic osteoarthritis
по: L.V. Host, и др.
Опубликовано: (2022-03-01)

Evaluating the Clinical Efficacy of Zoledronic Acid in the Prevention and Treatment of Osteoporosis in Postmenopausal Women, Compared with Conventional Medications
по: Fatemeh Rostami-Golmohammadi, и др.
Опубликовано: (2015-02-01)

Role of zoledronic acid in the prevention and treatment of osteoporosis
по: Räkel A, и др.
Опубликовано: (2011-03-01)

Zoledronic acid infusion for prevention and treatment of osteoporosis
по: John A Sunyecz
Опубликовано: (2010-10-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
по: Nataliya Vladimirovna Toroptsova, и др.
Опубликовано: (2011-06-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
по: Nataliya Vladimirovna Toroptsova, и др.
Опубликовано: (2011-06-01)

The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis
по: Deepak Kumar Khajuria, и др.
Опубликовано: (2014-01-01)

The effects of zoledronic acid treatment on depression and quality of life in women with postmenopausal osteoporosis: A clinical trial study
по: Feyzi Gokosmanoglu, и др.
Опубликовано: (2016-01-01)

Management of osteoporosis in the aging male: Focus on zoledronic acid
по: Paul K Piper Jr, и др.
Опубликовано: (2009-06-01)

Cardiovascular Safety in Postmenopausal Women and Men With Osteoporosis Treated With Denosumab and Zoledronic Acid: A Post‐Authorization Safety Study
по: Leslie Spangler, и др.
Опубликовано: (2023-10-01)

Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China
по: Ruxu You, и др.
Опубликовано: (2022-03-01)

Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D
по: Federica Bellone, и др.
Опубликовано: (2021-11-01)

How zoledronic acid improves osteoporosis by acting on osteoclasts
по: Biao Wang, и др.
Опубликовано: (2022-08-01)

ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS
по: S Yu Vorotnikova, и др.
Опубликовано: (2016-12-01)

Generic zoledronic acid for osteoporosis: focus on tolerability and safety
по: N. V. Toroptsova, и др.
Опубликовано: (2021-10-01)

Role of zoledronic acid in treatment of osteoporosis and prevention of fractures
по: A. V. Krivova, и др.
Опубликовано: (2022-01-01)

Zoledronate prevents bone loss after stroke
по: Poole, K, и др.
Опубликовано: (2006)

The effects of zoledronate on iliac bone remodelling in stroke patients
по: Poole, K, и др.
Опубликовано: (2007)

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
по: Ege Can Serefoglu, и др.
Опубликовано: (2010-05-01)

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
по: Luca Dalle Carbonare, и др.
Опубликовано: (2010-08-01)

Once-yearly zoledronic acid 5 mg therapy for osteoporosis: a focus on a patient
по: Irina Aleksandrovna Baranova, и др.
Опубликовано: (2011-09-01)

Once-yearly zoledronic acid 5 mg therapy for osteoporosis: a focus on a patient
по: Irina Aleksandrovna Baranova, и др.
Опубликовано: (2011-09-01)

Preserving hip bone mineral density following stroke using intravenous zoledronic acid: Findings from a 1 year randomised controlled trial
по: Poole, K, и др.
Опубликовано: (2004)

Pathogenesis and treatment of postmenopausal osteoporosis
по: Milhaud, G, и др.
Опубликовано: (1983)

Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia
по: Weilong Li, и др.
Опубликовано: (2024-11-01)

Annual Zoledronic Acid for the Treatment of Osteoporosis: A Randomized Controlled Trial
по: Asif Hussain, и др.
Опубликовано: (2023-01-01)

Zoledronic acid: challenges and pitfalls amid rehabilitation in primary osteoporosis and beyond
по: Alexandru Florin Florescu, и др.
Опубликовано: (2024-06-01)

Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip
по: Sanjay Agarwala, и др.
Опубликовано: (2019-06-01)

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients
по: Jun Xie, и др.
Опубликовано: (2019-12-01)

Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis
по: Johann D Ringe
Опубликовано: (2010-06-01)

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
по: Rol, и др.
Опубликовано: (2009-01-01)

EFFECT OF ZOLEDRONIC ACID THERAPY ON FRACTURE RISK IN THE TREATMENT OF MEN WITH OSTEOPOROSIS
по: Steven Boonen, и др.
Опубликовано: (2012-12-01)

Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients
по: Huang CF, и др.
Опубликовано: (2021-08-01)

The effects of zoledronate on iliac bone remodelling; a histomorphometric study in stroke patients
по: Poole, K, и др.
Опубликовано: (2007)

Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project
по: F. Bertoldo, и др.
Опубликовано: (2011-06-01)